 So, Ubenwa is a diagnostic tool for Bethaxphyxia. Just a bit on Bethaxphyxia, it's a condition that affects the brain of babies and can cause disability and death. And Bethaxphyxia is majorly low oxygen to the brain. Sorry, can we take that again? Can we take that again? So, Ubenwa is a diagnostic tool for Bethaxphyxia. Bethaxphyxia affects the brain of babies and can cause disability and death. Globally, it causes about 1.2 million deaths annually and then it's been costed to estimate about 61 billion dollars per year due to the death and disability from Bethaxphyxia. So, the science behind them, Ubenwa, is it's in research that there are alterations in the frequency of the cry of a child who has Bethaxphyxia. And what we're able to do was to, through artificial intelligence, develop an application that can be applied through mobile phones to record the cry of babies and tell if they've got Bethaxphyxia. And this is very good because it's just done in ten seconds. It's minimally invasive and it's low cost. It definitely can be deployed in low resource settings. At the moment, we've done our laboratory testing which has given us over 95% accuracy. What we look forward to in the nearest future is to do a clinical testing where we can have larger samples and this would be very good to understand Bethaxphyxia, the cry of a child. There have been different questions that have been asked even in this conference to know what's the difference in the cry frequency of a child from Asia. How is it different from that from a child in Africa or America? I mean, these are important questions to really ask. And if we're able to win the AI prize or raise funds for the next phase of this research, we'll generate data which will help even artificial intelligence globally in terms of frequency, voice frequency in children and to diagnose all the really related conditions in children. It's a very good work to invest in because at the moment, we're talking about sustainable development goals and we're looking at in 2030 to reduce neonatal and child mortality. And Bethaxphyxia actually is one of the top three causes of neonatal and children mortality. And so if we want to achieve reduction of this deadly condition, I mean, we need to invest into projects like this, which can detect the condition early and alert the health care workers and make sure they provide oxygen for these children, provide glucose for these children and take them to experts where we can prevent complications and death arising from this condition.